Elevance Health Beats Q1 2025 Earnings Estimates

Elevance Health (ELV) pre-announced a first-quarter 2025 earnings beat, reporting adjusted EPS of $11.97, surpassing both company guidance and Wall Street expectations despite higher Medicare Advantage costs. The company reaffirmed its annual adjusted net income guidance and projected Medicare Advantage membership to reach 2.3 million by 2025, with 35,000 more members gained than expected. Elevance's medical cost trends were in line with predictions, and its positive results stood out against UnitedHealth Group’s recent earnings miss, which had caused a sector-wide sell-off. The company's stock initially fell over 10% after UnitedHealth’s results but rebounded following its own announcement. Over five years, Elevance’s share price has grown 68%, though it still lags the broader market, with recent performance impacted by sector trends. Analysts view the Q1 results as strong and anticipate the full earnings release on April 22 may further influence the stock depending on management’s outlook.